Susquehanna International Group’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.7K Sell
1,592
-12,195
-88% -$119K ﹤0.01% 12886
2025
Q4
$159K Buy
13,787
+3,143
+30% +$48.5K ﹤0.01% 11118
2025
Q3
$259K Sell
10,644
-10,216
-49% -$170K ﹤0.01% 10453
2025
Q2
$343K Buy
20,860
+7,003
+51% +$121K ﹤0.01% 10042
2025
Q1
$252K Sell
13,857
-224
-2% -$6.4K ﹤0.01% 10447
2024
Q4
$522K Buy
14,081
+9,186
+188% +$351K ﹤0.01% 8557
2024
Q3
$157K Buy
4,895
+1,728
+55% +$95.9K ﹤0.01% 10703
2024
Q2
$260K Sell
3,167
-24,696
-89% -$2.67M ﹤0.01% 9772
2024
Q1
$4.04M Buy
27,863
+19,541
+235% +$1.65M ﹤0.01% 3996
2023
Q4
$766K Sell
8,322
-1,666
-17% -$169K ﹤0.01% 7644
2023
Q3
$1.65M Sell
9,988
-974
-9% -$127K ﹤0.01% 5536
2023
Q2
$693K Sell
10,962
-949
-8% -$57.5K ﹤0.01% 7543
2023
Q1
$404K Buy
11,911
+10,212
+601% +$533K ﹤0.01% 9073
2022
Q4
$98.2K Buy
+1,699
New +$105K ﹤0.01% 10979
2022
Q1
Sell
-347
Closed -$210K 13037
2021
Q4
$229K Sell
347
-1,829
-84% -$1.4M ﹤0.01% 11146
2021
Q3
$1.83M Buy
2,176
+925
+74% +$938K ﹤0.01% 6030
2021
Q2
$1.59M Buy
1,251
+1,015
+430% +$1.15M ﹤0.01% 6491
2021
Q1
$259K Sell
236
-2,722
-92% -$3.59M ﹤0.01% 10915
2020
Q4
$4.22M Buy
2,958
+958
+48% +$1.02M ﹤0.01% 3702
2020
Q3
$1.41M Buy
2,000
+847
+73% +$616K ﹤0.01% 5302
2020
Q2
$807K Sell
1,153
-109
-9% -$62.9K ﹤0.01% 6377
2020
Q1
$441K Buy
1,262
+217
+21% +$154K ﹤0.01% 7195
2019
Q4
$657K Buy
1,045
+251
+32% +$123K ﹤0.01% 6396
2019
Q3
$266K Buy
+794
New +$255K ﹤0.01% 8556

Other funds holding CDLX

Susquehanna International Group's CDLX Position: Q1 2026 in Review

Susquehanna International Group reduced its Cardlytics (CDLX) stake by 88% in Q1 2026, selling an estimated $119K and leaving 1,592 shares worth $16.7K. The position accounts for ﹤0.01% of the portfolio, ranked #12886.

Susquehanna International Group first reported a position in CDLX in Q3 2019 and has held it in 24 quarters since. The position peaked at $4.22M in Q4 2020. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.

  • Susquehanna International Group held 1,592 shares of Cardlytics worth $16.7K as of Q1 2026.
  • Susquehanna International Group sold 12,195 Cardlytics shares in Q1 2026, an estimated $119K.
  • Cardlytics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12886 holding.
  • Susquehanna International Group first reported a position in Cardlytics in Q3 2019 and has held it in 24 quarters since.
  • Susquehanna International Group's Cardlytics position peaked at $4.22M in Q4 2020.
  • 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.